Skip to content

The Research of Surgical Strategy in Takayasu Arteritis

The Research of Surgical Strategy in Takayasu Arteritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018752
Enrollment
Unknown
Registered
2018-10-08
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takayasu Arteritis

Interventions

Case series:open surgery

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Takayasu arteritis formulated by American rheumatology in 1990; 2. Meet the surgery operation indications which including 4 aspects. First, imageological examination show aortic or branch suffer severe stenosis(>70%) or occlusion. Second, refractory hypertension result from aortic or renal artery stenosis. Third, the appearance of heart, brain, limbs and other organs ischemic manifestations. Fourth, aortic aneurysm disease; 3. Aged 18 to 60 years old.

Exclusion criteria

Exclusion criteria: 1. Coexist with other Rheumatic autoimmune disease; 2. Coexist with severe hematopathy, endocrine disease, or tumor; 3. Coexist with severe damage of vital organs, such as heart, lung, liver or renal, and cannot tolerant the anesthesia and operation; 4. Coexist with acute or chronic infectious disease, except tuberculosis; 5. Insanity or other reasons that cannot cooperate; 6. Pregnant.

Design outcomes

Secondary

MeasureTime frame
inflammatory activity;Volume of inflammatory drug;Volume of hypotensive drugs;Volume of dehydrant;blood pressure;

Primary

MeasureTime frame
patency of bypass graft;life quality score;cardiovascular and cerebrovascular events;

Countries

China

Contacts

Public ContactLi Yongjun

Beijing Hospital

liyongjun4679@bjhmoh.cn+86 13501099799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026